Rheinmetall's Mixed Signals: A Loitering Munitions Breakthrough, a Lost Frigate, and a Market Still Weighing the Scales
Published on 08/14/2026 at 13:31 | Redaktion boerse-global.de
The defence sector rarely serves up a week quite like the one Rheinmetall has just delivered. Within the space of a few days, the Düsseldorf-based group has confirmed a landmark weapons test, seen its order book swell to a record €80.4 billion, and absorbed the loss of a multibillion-euro naval contract that forced management to trim its 2026 revenue guidance. Investors, for their part, have responded with cautious optimism — the shares have clawed back ground over the past month, though they remain a long way from the peaks of last autumn.
A Guidance Cut That Wasn't a Surprise
The headline-grabbing development came last Thursday, when Rheinmetall narrowed its 2026 sales forecast to a range of €13.7 billion to €14.2 billion. Reuters attributed the revision directly to the cancellation of Germany's F-126 frigate programme, a project that had promised the company a contract worth billions. The decision to pull the plug on the programme was not taken lightly by management. Chief executive Armin Papperger, speaking on Saturday, said he was "very dissatisfied" with the loss of the naval order, according to dpa.
Yet even as the company walked back its top-line expectations, the half-year figures released the same day painted a picture of a business firing on most cylinders. Second-quarter net profit after tax rose to €167 million from €157 million in the same period a year earlier. Earnings per share, however, slipped to €2.66 from €2.82 — a discrepancy that points to a larger share count than in the prior year. Revenue for the quarter jumped 69.8 percent to €3.289 billion, while operating profit surged 115 percent to €562 million. Crucially, the company reaffirmed its full-year margin target of around 19 percent even as it trimmed the revenue outlook.
While Rheinmetall navigates complex operational risks across its global supply chain, your own workplace faces its own set of hazards that need careful management. From manual handling to lone working, many employers underestimate the gaps in their safety documentation. A free toolkit with 41 ready-to-use templates and checklists helps you document and manage workplace risks effectively. Download the free Risk Assessment Toolkit
From FV-014 to a Fuller Order Book
Sandwiched between the earnings release and the guidance revision was a piece of news that underscored the breadth of Rheinmetall's technological ambitions. On Thursday, the company confirmed the successful test of its FV-014 loitering munition system, which was launched for the first time from a containerised rocket launcher mounted on an HX truck, achieving an operational range of 100 kilometres. The demonstration adds another long-range precision weapon to a portfolio that is already in high demand across Europe and beyond.
That demand is reflected in the numbers. The order backlog hit a record €80.4 billion, up 44 percent year-on-year. A significant chunk of that growth came from a series of contract wins and option exercises that have arrived with remarkable regularity. On Monday, the European procurement agency Occar announced the exercise of an option for 69 additional Boxer armoured vehicles — 35 for the German armed forces and 34 for the Dutch army. That brings the total order for the vehicle, produced jointly with KNDS, to 291 units. Option exercises are particularly valuable for Rheinmetall because they flow directly into the existing order book without the need for new tender processes.
The Boxer news followed a flurry of other announcements. American Rheinmetall, the group's US subsidiary, received an 18-month contract from the US Army in early August to develop autonomous military vehicles, working alongside partners Harbinger, Forterra and Primordial Labs. The British armed forces ordered weapon systems for RCH 155 wheeled howitzers in late July, a contract valued in the low triple-digit millions of euros, to be produced at a new facility in Telford. And a modernisation contract for the German Navy's frigate "Bayern", worth a mid-triple-digit million-euro amount, has been under way for roughly two weeks at the Neue Jadewerft, with work scheduled for completion by 2029.
Analysts Take Opposite Sides
The divergent news flow has left the analyst community split. RBC Capital Markets initiated coverage of the stock on 11 August with an Outperform rating, citing Rheinmetall's attractive positioning within the European rearmament cycle. The move came roughly a month after MWB Research withdrew its buy recommendation on 9 July, downgrading the stock in the wake of the NATO summit with reference to the reduced annual forecast and cut investments. The two ratings are separated by more than a month and should not be read as simultaneous reactions to the same news flow — but they do illustrate the uncertainty surrounding the company's valuation.
Papperger, for his part, has signalled that the company is not standing still. He warned that ramping up production of ATACMS missiles would take time, particularly as the United States simultaneously needs to replenish its own inventories. He also called for greater protection against drone attacks — a strategic shift that suggests the company is thinking beyond its traditional product lines.
The Chart Tells Its Own Story
The market's verdict on all of this has been cautiously positive. The shares closed Thursday at €1,173.60, and by Friday had advanced 2.2 percent to €1,199.80. Over the past 30 days, the stock is up 24 percent — or 22 percent on a monthly view, depending on the measurement period. The rally has been driven by the string of positive order announcements and the strong quarterly figures.
As global defence manufacturers scale up operations, ensuring workplace safety across facilities becomes ever more critical. UK regulations require proper risk assessments for hazardous substances, and failing to comply can lead to significant fines. A free COSHH toolkit with 43 customisable templates, checklists and toolbox talks helps you meet your legal obligations without hours of paperwork. Get the free COSHH Toolkit
Yet the recovery remains incomplete. The stock is still 40 percent below its highs of around €2,000 reached in October, and 42 percent off the 52-week peak of €2,007.00. It sits 33 percent above its year-to-date low of €902.50, and remains down 24 percent since the start of the year. The distance from the autumn highs suggests that while the market is rewarding the recent positive news flow, the scepticism generated by the guidance cut has not been fully priced out. For investors, the central question is whether the operational momentum visible across multiple continents can eventually translate into a more sustained share-price recovery — the recent movement offers early indications, but the verdict is far from settled.
